2015 Antineoplastics

STIs that target Bcr-Abl: DASATINIB, IMATINIB, NILOTINIB

Resistance

IMATINIB

Email: Dr. Janet Fitzakerley | ©2015 University of Minnesota Medical School Duluth | Last modified: 11-apr-15 9:39 AM